Eight-plasmid system for rapid generation of influenza virus vaccines.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Vaccine

• Publication date

  2002-08-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(02)00268-2PMID 12163268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rescue of influenza A virus from recombinant DNA.

  2007cited by this paper
• Characterization of H5N1 Influenza Viruses That Continue To Circulate in Geese in Southeastern China

  2002cited by this paper
• Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses

  2001cited by this paper
• Characterization of a Porcine Lung Epithelial Cell Line Suitable for Influenza Virus Studies

  2001cited by this paper
• Universal primer set for the full-length amplification of all influenza A viruses

  2001influential reference
• Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

  2000cited by this paper
• A DNA transfection system for generation of influenza A virus from eight plasmids.

  2000influential reference
• Characterization of the Influenza A Virus Gene Pool in Avian Species in Southern China: Was H6N1 a Derivative or a Precursor of H5N1?

  2000cited by this paper
• Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?

  1999influential reference
• Development of a Vero cell-derived influenza whole virus vaccine.

  1999cited by this paper
• Human infection with influenza H9N2.

  1999cited by this paper
• Generation of influenza A viruses entirely from cloned cDNAs.

  1999cited by this paper
• Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium.

  1999cited by this paper
• Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.

  1999cited by this paper
• Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong.

  1999cited by this paper
• Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

  1998cited by this paper
• A pandemic warning?

  1997cited by this paper
• avian influenza virus

  1997cited by this paper
• African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses

  1996cited by this paper
• Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective

  1995cited by this paper
• The TATA-binding protein and associated factors are integral components of the RNA polymerase I transcription factor, SL1.

  1992cited by this paper
• Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus.

  1987cited by this paper
• Evidence for host-cell selection of influenza virus antigenic variants

  1983cited by this paper
• Future influenza vaccines and the use of genetic recombinants.

  1969cited by this paper

• Dual roles for influenza A protein PA-X: limiting inflammatory response and disrupting MHC I antigen presentation in human respiratory epithelium

  2026cites this paper
• Development of an inactivated H9N2 subtype avian influenza serological DIVA vaccine using the chimeric A/B NA epitope approach.

  2026cites this paper
• N-terminal acetylation controls multiple functional aspects of the influenza A virus ribonuclease PA-X

  2026cites this paper
• MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses.

  2026cites this paper
• The RNA-Binding Domain NS1 of Influenza as an Antiviral Target: From Evolutionary Conservation Mapping to Experimental Validation

  2026cites this paper
• Sequential aerosol and oral immunization with a bivalent H9N2/H5N2 vaccine protects against H5N1 and H9N2 avian influenza challenges

  2025cites this paper
• Evolutionary trajectories and zoonotic potential of a PB2 mutation triad (I147T, K339T, and A588T) in avian influenza viruses

  2025cites this paper
• NSUN2-dependent 5-methylcytosine Modification Regulates Influenza A virus Gene Expression and Genomic Packaging

  2025cites this paper
• A Host Cell Vector Model for Analyzing Viral Protective Antigens and Host Immunity

  2025cites this paper
• Vaccine dosage haemagglutinin concentration required to protect birds against highly pathogenic avian influenza A(H7N3) virus and reduce viral replication

  2025cites this paper
• Vaccine-induced antigenic drift of a human-origin H3N2 Influenza A virus in swine alters glycan binding and sialic acid avidity

  2025cites this paper
• A High-Yield Recombinant Inactivated Whole-Virion Nasal Influenza A(H1N1)pdm09 Virus Vaccine with an Attenuated PB2 Gene

  2025cites this paper
• Anti-neuraminidase antibody responses in older adults after consecutive vaccinations with enhanced influenza vaccines: a randomized controlled trial.

  2025cites this paper
• Genetic Optimization of Early 2009 Pandemic H1N1 Vaccine Strains for Improved Replication in Embryonated Chicken Eggs

  2025cites this paper
• Immunogenicity and efficacy of commercial poultry avian influenza vaccines against HPAI A(H5N1) clade 2.3.4.4b viruses in Mexico.

  2025cites this paper
• hnRNPM regulates influenza A virus replication through distinct mechanisms in human and avian cells: implications for cross-species transmission

  2025cites this paper
• A Model H5N2 Vaccine Strain for Dual Protection Against H5N1 and H9N2 Avian Influenza Viruses

  2024cites this paper
• Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors

  2024cites this paper
• Production of Disinfective Coating Layer to Facial Masks Supplemented with Camellia sinensis Extract

  2024cites this paper
• Optimized properties of live vaccine influenza reassortant strains obtained by reverse genetics

  2024cites this paper
• The evolution of hemagglutinin-158 and neuraminidase-88 glycosylation sites modulates antigenicity and pathogenicity of clade 2.3.2.1 H5N1 avian influenza viruses.

  2024cites this paper
• Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus

  2024cites this paper
• Efficacy of the H7N9 vaccine as a candidate for the Korean avian influenza antigen bank.

  2024cites this paper
• Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine

  2024cites this paper
• Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets

  2024cites this paper
• Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens.

  2023cites this paper
• CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine

  2023cites this paper
• Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations in vivo

  2023cites this paper
• Chimeric Viruses Containing Select Agents: The Biology Behind Their Creation, Attenuation, and Exclusion From Regulation

  2023cites this paper
• E3 ligase HECTD3 promotes RNA virus replication and virus-induced inflammation via K33-linked polyubiquitination of PKR

  2023cites this paper
• Advanced fluorescence microscopy in respiratory virus cell biology.

  2023cites this paper
• Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America

  2023cites this paper
• Single-Dose Intranasal Immunisation with Novel Chimeric H1N1 Expressing the Receptor-Binding Domain of SARS-CoV-2 Induces Robust Mucosal Immunity, Tissue-Resident Memory T Cells, and Heterologous Protection in Mice

  2023cites this paper
• Expanding the anti-flaviviral arsenal: Discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV.

  2023cites this paper
• The efficacy of an inactivated avian influenza H5N1 vaccine against an African strain of HPAI H5N8 (clade 2.3.4.4 B)

  2023cites this paper
• Antibodies elicited by Newcastle disease virus-vectored H7N9 avian influenza vaccine are functional in activating the complement system

  2023cites this paper
• Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses

  2023cites this paper
• Determination of cold-adapted influenza virus (Orthomyxoviridae: Alphainfluenzavirus) polymerase activity by the minigenome method with a fluorescent protein.

  2023cites this paper
• Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza a and B viruses.

  2023cites this paper
• Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity

  2023cites this paper
• N-terminal acetylation controls multiple functional aspects of the influenza A virus ribonuclease PA-X

  2023cites this paper
• Determining optimal conditions for growing recombinant vectors to be used in developing a bovine tuberculosis vaccine

  2023cites this paper
• Addition of Camellia sinensis extract to water to disinfect respiratory viruses accumulated over different surfaces.

  2022cites this paper
• Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA as a major determinant for antigen yield.

  2022cites this paper
• Generation of a live attenuated influenza A vaccine by proteolysis targeting

  2022cites this paper
• Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein

  2022cites this paper
• Influenza A virus polymerase acidic protein E23R substitution is a marker of reduced susceptibility to baloxavir.

  2022cites this paper
• Coinfection of Chickens with H9N2 and H7N9 Avian Influenza Viruses Leads to Emergence of Reassortant H9N9 Virus with Increased Fitness for Poultry and a Zoonotic Potential

  2022cites this paper
• Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice

  2022cites this paper
• Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity.

  2022cites this paper
• Updating the National Antigen Bank in Korea: Protective Efficacy of Synthetic Vaccine Candidates against H5Nx Highly Pathogenic Avian Influenza Viruses Belonging to Clades 2.3.2.1 and 2.3.4.4

  2022cites this paper
• Effect of E23 G/K, F36V, N37T, E119D, and E199G polymerase acidic protein substitutions on the replication and baloxavir susceptibility of influenza B viruses.

  2022cites this paper
• Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission

  2022cites this paper
• Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs

  2022cites this paper
• The Hierarchical Sequence Requirements of the H1 Subtype-Specific Noncoding Regions of Influenza A Virus

  2022cites this paper
• Generation, characterization, and protective ability of mouse monoclonal antibodies against the HA of A (H1N1) influenza virus

  2022cites this paper
• Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles

  2021cites this paper
• Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity

  2021cites this paper
• NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.

  2021cites this paper
• MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells

  2021cites this paper
• Multiple Gene Segments Are Associated with Enhanced Virulence of Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Virus in Mallards

  2021cites this paper
• In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression

  2021cites this paper
• Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine

  2021cites this paper
• Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles

  2021cites this paper
• DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response

  2021cites this paper
• PB1-F2 amyloid-like fibers correlate with proinflammatory signaling and respiratory distress in influenza-infected mice

  2021cites this paper
• Glycolytic and immunological alterations in human U937 monocytes in response to H1N1 infection

  2020cites this paper
• Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

  2020cites this paper
• A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine

  2020cites this paper
• Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.

  2020cites this paper
• Truncation or Deglycosylation of the Neuraminidase Stalk Enhances the Pathogenicity of the H5N1 Subtype Avian Influenza Virus in Mallard Ducks

  2020cites this paper
• Mutation of the second sialic acid-binding site of influenza A virus neuraminidase drives compensatory mutations in hemagglutinin

  2020cites this paper
• Characterizing Emerging Canine H3 Influenza Viruses

  2020cites this paper
• Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies

  2020cites this paper
• Rank orders of mammalian pathogenicity-related PB2 mutations of avian influenza A viruses

  2020cites this paper
• H1N1 Infection Reduces Glucose Level in Human U937 Monocytes Culture

  2020cites this paper
• Alveolar macrophage‐derived extracellular vesicles inhibit endosomal fusion of influenza virus

  2020cites this paper
• Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility

  2020cites this paper
• Hemagglutinin-Specific Non-neutralizing Antibody Is Essential for Protection Provided by Inactivated and Viral-Vectored H7N9 Avian Influenza Vaccines in Chickens

  2020cites this paper
• Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase Functions

  2020cites this paper
• Detection and Titration of Influenza A Virus Neuraminidase Inhibiting (NAI) Antibodies Using an Enzyme-Linked Lectin Assay (ELLA).

  2020cites this paper
• Protective efficacy of vaccines of the Korea national antigen bank against the homologous H5Nx clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses.

  2020cites this paper
• Avian influenza

  2020cites this paper
• Trial for Preparation and Evaluation of Combined Inactivated Vaccine for the Protection against Riemerella anatipestifer and Avian Influenza (H5N1) in Ducks

  2020cites this paper
• Influenza A viruses serially passaged in different MDCK cell lines exhibit limited sequence variation across their genomes, with the exception of the hemagglutinin gene

  2020cites this paper
• Adsorptive mutation and N-linked glycosylation modulate influenza virus antigenicity and fitness

  2020cites this paper
• Evolution of H 5 N 1 Avian Influenza Viruses in Asia

  2019cites this paper
• 47 / 2001 ( H 7 N 1 ) in chicks

  2019cites this paper
• Evolution of H 5 N 1 Avian Influenza Viruses in Asia

  2019cites this paper
• Evolution of H 5 N 1 Avian Influenza Viruses in Asia

  2019cites this paper
• Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.

  2019cites this paper
• A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections

  2019cites this paper
• A system for production of defective interfering particles in the absence of infectious influenza A virus

  2019cites this paper
• The effects of modified sialic acids on mucus and erythrocytes on influenza A virus HA and NA functions

  2019cites this paper
• Memory CD4+ T cells enhance B‐cell responses to drifting influenza immunization

  2019cites this paper
• An alternative AUG codon in segment 5 of the 2009 pandemic influenza A virus is a swine-derived virulence motif

  2019cites this paper
• Expression of 9-O- and 7,9-O-Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza Viruses

  2019cites this paper
• Novel Mutations Evading Avian Immunity around the Receptor Binding Site of the Clade 2.3.2.1c Hemagglutinin Gene Reduce Viral Thermostability and Mammalian Pathogenicity

  2019cites this paper
• Generation of highly productive and mammalian nonpathogenic recombinant H9N2 avian influenza viruses by optimization of 3'end promoter and NS genome.

  2019cites this paper
• Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it

  2019cites this paper